Furthermore, Lp-PLA2 may serveas a biomarker for sub-acute stroke patients receiving treatment with GDLMI [6].Elevated levels of ischemia-modified albumin (IMA), a kind of serum albumin, arefrequently indicative of AIS progression [7]. This evidence concerns the gene ALB and androgen insensitivity syndrome.